1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,080 | 1,155 | 11:40 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Tevogen Bio erweitert Bürofläche in New Jersey durch wichtigen Nachtrag | 2 | Investing.com Deutsch | ||
| Di | Tevogen Bio Holdings Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Tevogen Bio erweitert KI-Initiative in der Immuntherapie-Entwicklung | 4 | Investing.com Deutsch | ||
| Fr | Tevogen Bio expands AI in immunotherapy development | 1 | Investing.com | ||
| Fr | Tevogen Bio Inc: Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships | 4 | GlobeNewswire (USA) | ||
| 26.05. | Tevogen Peports Plans to Increase the Target Population for TVGN 489 | 2 | Insider Monkey | ||
| 23.05. | Tevogen expands target for COVID treatment to seniors | 1 | Investing.com | ||
| 23.05. | Tevogen erweitert Zielgruppe für COVID-Behandlung auf Senioren | 3 | Investing.com Deutsch | ||
| TEVOGEN BIO Aktie jetzt für 0€ handeln | |||||
| 23.05. | Tevogen Bio Inc: Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow | 110 | GlobeNewswire (Europe) | WARREN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), today announced a planned expansion of TVGN 489's target population to include patients... ► Artikel lesen | |
| 22.05. | Tevogen Bio Inc: Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting | 75 | GlobeNewswire (Europe) | WARREN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), today announced that it will provide several updates to stockholders in advance of... ► Artikel lesen | |
| 14.05. | Tevogen Bio Holdings Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.05. | Tevogen Bio Inc: Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation | 99 | GlobeNewswire (Europe) | WARREN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN). As the biopharma industry faces increasing competition from international markets... ► Artikel lesen | |
| 01.05. | Tevogen Bio Holdings Inc. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 30.04. | Tevogen Bio Inc: CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment | 58 | GlobeNewswire (Europe) | WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that CD8 Technology Services LLC ("CD8") has signed a letter of intent... ► Artikel lesen | |
| 29.04. | Tevogen Bio shares surge on revenue forecast | 2 | Investing.com | ||
| 29.04. | Tevogen Bio-Aktien steigen nach Umsatzprognose | 3 | Investing.com Deutsch | ||
| 29.04. | Tevogen hebt Vorteile von DRS-Konten für Aktionäre hervor | 1 | Investing.com Deutsch | ||
| 29.04. | Tevogen highlights DRS account benefits for shareholders | 1 | Investing.com | ||
| 29.04. | Tevogen Bio Inc: Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts | 73 | GlobeNewswire (Europe) | WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), today informed shareholders about several differences between holding shares in... ► Artikel lesen | |
| 28.04. | Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On? | 5 | Benzinga.com |
Seite:
1 2 3 4 5 Weiter >>
89 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 40,300 | -0,06 % | BERENBERG stuft QIAGEN NV auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Qiagen mit einem Kursziel von 48 Euro auf "Buy" belassen. Der Tenor auf der Berenberg-MedTech-Investorenkonferenz in Manhatten... ► Artikel lesen | |
| AMGEN | 252,35 | +0,34 % | Amgen Says Imdelltra Cut Risk Of Death By 40% In Small Cell Lung Cancer Patients | THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) Monday announced positive interim results from the Phase 3 DeLLphi-304 study showing Imdelltra reduced the risk of death by 40% and significantly... ► Artikel lesen | |
| NOVAVAX | 6,251 | -0,16 % | Schock-News für Novavax Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| PALATIN TECHNOLOGIES | 0,079 | -0,13 % | Palatin Technologies Q1 Net Loss Narrows On Lower Expenses | WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTNT.PK), a biopharmaceutical company, on Wednesday reported narrower net loss in its first quarter with sharply lower operating expenses.Palatin... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 429,90 | +1,18 % | Nasdaq 100 verliert 1,01 Prozent - Regeneron Pharmaceuticals mit größtem Kursverlust (21.148 Pkt.) | Für den Nasdaq 100-Index brachte der bisherige Aktienhandel heute leichte Verluste. Derzeit liegt das Kursbarometer mit 1,01 Prozent im Minus. Die Bären haben sich aktuell im Wertpapierhandel knapp... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,910 | 0,00 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem gibt Finanzierung mittels Wandelschuldverschreibung bekannt | Vancouver, British Columbia, 22. April 2025 / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) ("Sirona" oder das "Unternehmen") gibt eine nicht vermittelte Privatplatzierung... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 3,240 | -1,82 % | COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders | Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 9,610 | -0,52 % | BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted... ► Artikel lesen | |
| BIOMARIN PHARMACEUTICAL | 49,940 | +1,61 % | BioMarin To Acquire Inozyme Pharma For About $270 Mln In Cash | WASHINGTON (dpa-AFX) - BioMarin Pharmaceutical Inc. (BMRN) and Inozyme Pharma, Inc. (INZY) Friday said that BioMarin has agreed to acquire Inozyme for about $270 million or $4 per share, in... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,478 | +5,75 % | NurExone stärkt US-Präsenz und bereitet klinische Studien vor | ||
| ARROWHEAD PHARMACEUTICALS | 14,860 | +1,33 % | Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses' | ||
| XOMA ROYALTY | 21,400 | -2,73 % | XOMA Royalty Corp - 8-K, Current Report | ||
| T2 BIOSYSTEMS | 0,105 | -3,67 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2025.ISIN NameCA24703H1029 DELIVRA... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 2,085 | 0,00 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference | Marlborough, Massachusetts--(Newsfile Corp. - May 19, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary... ► Artikel lesen |
Das Unternehmen TEVOGEN BIO HOLDINGS INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,025 (-2,20 %) liegt der Kurs bei 1,110 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TEVOGEN BIO HOLDINGS INC finden Sie auf Wallstreet Online.